Levels of 5-methyltetrahydrofolate and ascorbic acid in cerebrospinal fluid are correlated: Implications for the accelerated degradation of folate by reactive oxygen species |
| |
Authors: | Sophie-Beth Aylett Viruna Neergheen Iain P. Hargreaves Simon Eaton John M. Land Shamima Rahman Simon J.R. Heales |
| |
Affiliation: | 1. Clinical and Molecular Genetics Unit, UCL Institute of Child Health, London, UK;2. Paediatric Surgery Unit, UCL Institute of Child Health, London, UK;3. Neurometabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK;4. Chemical Pathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK |
| |
Abstract: | Deficiency of 5-methyltetrahydrofolate (5-MTHF) in cerebrospinal fluid (CSF) is associated with a number of neurometabolic conditions including mitochondrial electron transport chain defects. Whilst failure of the active transport of 5-methyltetrahydrofolate (5-MTHF) into the CSF compartment has been proposed as a potential mechanism responsible for the 5-MTHF deficiency seen in mitochondrial disorders, it is becoming increasingly clear that other mechanisms are involved. Here, we have considered the role of oxidative stress as a contributing mechanism. Concerning, ascorbic acid (AA), we have established a CSF reference range (103–303 μM) and demonstrated a significant positive correlation between 5-MTHF and AA. Furthermore, CSF itself was also shown to convey antioxidant properties towards 5-MTHF. However, this protection could be overcome by the introduction of a hydroxyl radical generating system. Using a neuronal model system, inhibition of mitochondrial complex I, by 58%, was associated with a 23% increase in superoxide generation and a significantly increased loss of 5-MTHF from the extracellular medium. Addition of AA (150 μM) was able to prevent this increased 5-MTHF catabolism. We conclude that increased generation of reactive oxygen species and/or loss of CSF antioxidants are also factors to consider with regard to the development of a central 5-MTHF deficiency. Co-supplementation of AA together with appropriate folate replacement may be of therapeutic benefit. |
| |
Keywords: | Oxidative stress Mitochondrial disease Folate 5-Methyltetrahydrofolate |
本文献已被 ScienceDirect 等数据库收录! |
|